Annual report

Period2023-10-01 → 2024-09-30
Filed2024-12-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed

Amends S100UYNL. Amended by S100V0EI (2024-12-25).

Key figures · 158
MetricValuePeriodScopeSource row
Revenue¥19.8bn2023-10-01 → 2024-09-30Cons.Net sales
Revenue¥26.6bn2022-10-01 → 2023-09-30Cons.Net sales
Revenue¥29.8bn2021-10-01 → 2022-09-30dCons.Net sales (5-year summary)
Revenue¥26.3bn2020-10-01 → 2021-09-30dCons.Net sales (5-year summary)
Revenue¥22.0bn2019-10-01 → 2020-09-30dCons.Net sales (5-year summary)
Operating income¥178m2023-10-01 → 2024-09-30Cons.Operating income
Operating income¥440m2022-10-01 → 2023-09-30Cons.Operating income
Ordinary income¥181m2023-10-01 → 2024-09-30Cons.Ordinary income
Ordinary income¥432m2022-10-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥710m2021-10-01 → 2022-09-30dCons.Ordinary income loss (5-year summary)
Ordinary income¥596m2020-10-01 → 2021-09-30dCons.Ordinary income loss (5-year summary)
Ordinary income¥207m2019-10-01 → 2020-09-30dCons.Ordinary income loss (5-year summary)
Profit before tax¥274m2023-10-01 → 2024-09-30Cons.Income before income taxes
Profit before tax¥432m2022-10-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)¥136m2023-10-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥271m2022-10-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥437m2021-10-01 → 2022-09-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥391m2020-10-01 → 2021-09-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥121m2019-10-01 → 2020-09-30dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥155m2023-10-01 → 2024-09-30Cons.Profit loss
Net income¥286m2022-10-01 → 2023-09-30Cons.Profit loss
Total assets¥10.7bnat 2024-09-30Cons.Assets
Total assets¥14.7bnat 2023-09-30Cons.Assets
Total assets¥13.5bnat 2022-09-30dCons.Total assets (5-year summary)
Total assets¥13.0bnat 2021-09-30dCons.Total assets (5-year summary)
Total assets¥13.4bnat 2020-09-30dCons.Total assets (5-year summary)
Total liabilities¥4.9bnat 2024-09-30Cons.Liabilities
Total liabilities¥9.0bnat 2023-09-30Cons.Liabilities
Net assets / equity¥5.7bnat 2024-09-30Cons.Net assets
Net assets / equity¥5.7bnat 2023-09-30Cons.Net assets
Net assets / equity¥5.5bnat 2022-09-30dCons.Net assets
Net assets / equity¥5.2bnat 2021-09-30dCons.Net assets (5-year summary)
Net assets / equity¥4.8bnat 2020-09-30dCons.Net assets (5-year summary)
Cash and deposits¥5.6bnat 2024-09-30Cons.Cash and deposits
Cash and deposits¥5.5bnat 2023-09-30Cons.Cash and deposits
Cash & equivalents¥5.6bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥5.5bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥5.5bnat 2022-09-30dCons.Cash and cash equivalents
Cash & equivalents¥5.4bnat 2021-09-30dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥4.4bnat 2020-09-30dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥33m2023-10-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥342m2022-10-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥242m2021-10-01 → 2022-09-30dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.3bn2020-10-01 → 2021-09-30dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.9bn2019-10-01 → 2020-09-30dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow¥101m2023-10-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥82m2022-10-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥50m2021-10-01 → 2022-09-30dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥42m2020-10-01 → 2021-09-30dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥64m2019-10-01 → 2020-09-30dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥97m2023-10-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥202m2022-10-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥121m2021-10-01 → 2022-09-30dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥298m2020-10-01 → 2021-09-30dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥238m2019-10-01 → 2020-09-30dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥23.092023-10-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥46.122022-10-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥74.32021-10-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥66.642020-10-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥20.842019-10-01 → 2020-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥22.962023-10-01 → 2024-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥45.842022-10-01 → 2023-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥73.842021-10-01 → 2022-09-30dCons.Diluted earnings per share (5-year summary)
EPS (diluted)¥66.112020-10-01 → 2021-09-30dCons.Diluted earnings per share (5-year summary)
EPS (diluted)¥20.622019-10-01 → 2020-09-30dCons.Diluted earnings per share (5-year summary)
Net assets per share¥943.51at 2024-09-30Cons.Net assets per share (5-year summary)
Net assets per share¥946.33at 2023-09-30Cons.Net assets per share (5-year summary)
Net assets per share¥915.42at 2022-09-30dCons.Net assets per share (5-year summary)
Net assets per share¥855.78at 2021-09-30dCons.Net assets per share (5-year summary)
Net assets per share¥802.93at 2020-09-30dCons.Net assets per share (5-year summary)
Equity ratio52.3%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio37.9%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio40.0%at 2022-09-30dCons.Equity to asset ratio (5-year summary)
Equity ratio38.8%at 2021-09-30dCons.Equity to asset ratio (5-year summary)
Equity ratio35.1%at 2020-09-30dCons.Equity to asset ratio (5-year summary)
ROE2.4%2023-10-01 → 2024-09-30Cons.Rate of return on equity (5-year summary)
ROE5.0%2022-10-01 → 2023-09-30Cons.Rate of return on equity (5-year summary)
ROE8.4%2021-10-01 → 2022-09-30dCons.Rate of return on equity (5-year summary)
ROE8.0%2020-10-01 → 2021-09-30dCons.Rate of return on equity (5-year summary)
ROE2.7%2019-10-01 → 2020-09-30dCons.Rate of return on equity (5-year summary)
Employees170at 2024-09-30Cons.Number of employees
Employees176at 2023-09-30Cons.Number of employees
Employees175at 2022-09-30dCons.Number of employees
Employees162at 2021-09-30dCons.Number of employees
Employees157at 2020-09-30dCons.Number of employees
Revenue¥17.4bn2023-10-01 → 2024-09-30StandaloneNet sales
Revenue¥24.0bn2022-10-01 → 2023-09-30StandaloneNet sales
Revenue¥27.3bn2021-10-01 → 2022-09-30dStandaloneNet sales (5-year summary)
Revenue¥23.4bn2020-10-01 → 2021-09-30dStandaloneNet sales (5-year summary)
Revenue¥19.7bn2019-10-01 → 2020-09-30dStandaloneNet sales (5-year summary)
Operating income−¥40m2023-10-01 → 2024-09-30StandaloneOperating income
Operating income¥317m2022-10-01 → 2023-09-30StandaloneOperating income
Ordinary income−¥16m2023-10-01 → 2024-09-30StandaloneOrdinary income
Ordinary income¥362m2022-10-01 → 2023-09-30StandaloneOrdinary income
Ordinary income¥448m2021-10-01 → 2022-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥435m2020-10-01 → 2021-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥234m2019-10-01 → 2020-09-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥77m2023-10-01 → 2024-09-30StandaloneIncome before income taxes
Profit before tax¥362m2022-10-01 → 2023-09-30StandaloneIncome before income taxes
Net income¥44m2023-10-01 → 2024-09-30StandaloneProfit loss
Net income¥269m2022-10-01 → 2023-09-30StandaloneProfit loss
Net income¥294m2021-10-01 → 2022-09-30dStandaloneNet income loss (5-year summary)
Net income¥297m2020-10-01 → 2021-09-30dStandaloneNet income loss (5-year summary)
Net income¥194m2019-10-01 → 2020-09-30dStandaloneNet income loss (5-year summary)
Total assets¥9.5bnat 2024-09-30StandaloneAssets
Total assets¥13.7bnat 2023-09-30StandaloneAssets
Total assets¥12.3bnat 2022-09-30dStandaloneTotal assets (5-year summary)
Total assets¥11.8bnat 2021-09-30dStandaloneTotal assets (5-year summary)
Total assets¥12.7bnat 2020-09-30dStandaloneTotal assets (5-year summary)
Total liabilities¥4.3bnat 2024-09-30StandaloneLiabilities
Total liabilities¥8.5bnat 2023-09-30StandaloneLiabilities
Net assets / equity¥5.1bnat 2024-09-30StandaloneNet assets
Net assets / equity¥5.2bnat 2023-09-30StandaloneNet assets
Net assets / equity¥5.0bnat 2022-09-30dStandaloneNet assets
Net assets / equity¥4.8bnat 2021-09-30dStandaloneNet assets (5-year summary)
Net assets / equity¥4.6bnat 2020-09-30dStandaloneNet assets (5-year summary)
Cash and deposits¥4.5bnat 2024-09-30StandaloneCash and deposits
Cash and deposits¥4.7bnat 2023-09-30StandaloneCash and deposits
EPS (basic)¥7.522023-10-01 → 2024-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥45.72022-10-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥49.912021-10-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥50.542020-10-01 → 2021-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥33.532019-10-01 → 2020-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥7.482023-10-01 → 2024-09-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥45.422022-10-01 → 2023-09-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥49.62021-10-01 → 2022-09-30dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥50.142020-10-01 → 2021-09-30dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥33.182019-10-01 → 2020-09-30dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥502023-10-01 → 2024-09-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥502022-10-01 → 2023-09-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥502021-10-01 → 2022-09-30dStandaloneDividend paid per share (5-year summary)
Dividend per share¥402020-10-01 → 2021-09-30dStandaloneDividend paid per share (5-year summary)
Dividend per share¥452019-10-01 → 2020-09-30dStandaloneDividend paid per share (5-year summary)
Net assets per share¥865.93at 2024-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥884.07at 2023-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥853.57at 2022-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥818.33at 2021-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥781.47at 2020-09-30dStandaloneNet assets per share (5-year summary)
Equity ratio54.0%at 2024-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio38.0%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio40.9%at 2022-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio40.9%at 2021-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio36.2%at 2020-09-30dStandaloneEquity to asset ratio (5-year summary)
ROE0.9%2023-10-01 → 2024-09-30StandaloneRate of return on equity (5-year summary)
ROE5.3%2022-10-01 → 2023-09-30StandaloneRate of return on equity (5-year summary)
ROE6.0%2021-10-01 → 2022-09-30dStandaloneRate of return on equity (5-year summary)
ROE6.3%2020-10-01 → 2021-09-30dStandaloneRate of return on equity (5-year summary)
ROE4.5%2019-10-01 → 2020-09-30dStandaloneRate of return on equity (5-year summary)
Shares issued1,967,800at 2024-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued1,960,800at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued1,960,800at 2022-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,960,800at 2021-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,954,400at 2020-09-30dStandaloneTotal number of issued shares (5-year summary)
Employees134at 2024-09-30StandaloneNumber of employees
Employees137at 2023-09-30StandaloneNumber of employees
Employees134at 2022-09-30dStandaloneNumber of employees
Employees118at 2021-09-30dStandaloneNumber of employees
Employees114at 2020-09-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 57
SegmentItemPeriodValue
Reconciling Itemsreconcilingdepreciation2023-10-01 → 2024-09-30−¥17,000
Reconciling Itemsreconcilingsegment assetsat 2024-09-30−¥146m
Reconciling Itemsreconcilingsegment profit2023-10-01 → 2024-09-30¥2m
Food Servicereportable segmentdepreciation2023-10-01 → 2024-09-30¥3m
Food Servicereportable segmentemployeesat 2024-09-309 pure
Food Servicereportable segmentrevenue2023-10-01 → 2024-09-30¥416m
Food Servicereportable segmentrevenue external2023-10-01 → 2024-09-30¥416m
Food Servicereportable segmentsegment assetsat 2024-09-30¥191m
Food Servicereportable segmentsegment profit2023-10-01 → 2024-09-30¥14m
Remote Image Diagnosis Service Businessreportable segmentcapex2023-10-01 → 2024-09-30¥7m
Remote Image Diagnosis Service Businessreportable segmentdepreciation2023-10-01 → 2024-09-30¥21m
Remote Image Diagnosis Service Businessreportable segmentemployeesat 2024-09-3013 pure
Remote Image Diagnosis Service Businessreportable segmentrevenue2023-10-01 → 2024-09-30¥778m
Remote Image Diagnosis Service Businessreportable segmentrevenue external2023-10-01 → 2024-09-30¥778m
Remote Image Diagnosis Service Businessreportable segmentsegment assetsat 2024-09-30¥624m
Remote Image Diagnosis Service Businessreportable segmentsegment profit2023-10-01 → 2024-09-30¥67m
Total Medical Solution Businessreportable segmentcapex2023-10-01 → 2024-09-30¥37m
Total Medical Solution Businessreportable segmentdepreciation2023-10-01 → 2024-09-30¥76m
Total Medical Solution Businessreportable segmentemployeesat 2024-09-30148 pure
Total Medical Solution Businessreportable segmentrevenue2023-10-01 → 2024-09-30¥18.6bn
Total Medical Solution Businessreportable segmentrevenue external2023-10-01 → 2024-09-30¥18.6bn
Total Medical Solution Businessreportable segmentsegment assetsat 2024-09-30¥10.0bn
Total Medical Solution Businessreportable segmentsegment profit2023-10-01 → 2024-09-30¥95m
Total Of Reportable Segments And Otherssegment totalcapex2023-10-01 → 2024-09-30¥44m
Total Of Reportable Segments And Otherssegment totaldepreciation2023-10-01 → 2024-09-30¥100m
Total Of Reportable Segments And Otherssegment totalrevenue2023-10-01 → 2024-09-30¥19.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-10-01 → 2024-09-30¥19.8bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2024-09-30¥10.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-10-01 → 2024-09-30¥176m
Reconciling Itemsreconcilingdepreciation2022-10-01 → 2023-09-30−¥26,000
Reconciling Itemsreconcilingsegment assetsat 2023-09-30−¥146m
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2023-09-30¥2m
Food Servicereportable segmentcapex2022-10-01 → 2023-09-30¥552,000
Food Servicereportable segmentdepreciation2022-10-01 → 2023-09-30¥4m
Food Servicereportable segmentrevenue2022-10-01 → 2023-09-30¥404m
Food Servicereportable segmentrevenue external2022-10-01 → 2023-09-30¥404m
Food Servicereportable segmentsegment assetsat 2023-09-30¥198m
Food Servicereportable segmentsegment profit2022-10-01 → 2023-09-30¥11m
Remote Image Diagnosis Service Businessreportable segmentcapex2022-10-01 → 2023-09-30¥50m
Remote Image Diagnosis Service Businessreportable segmentdepreciation2022-10-01 → 2023-09-30¥20m
Remote Image Diagnosis Service Businessreportable segmentrevenue2022-10-01 → 2023-09-30¥725m
Remote Image Diagnosis Service Businessreportable segmentrevenue external2022-10-01 → 2023-09-30¥725m
Remote Image Diagnosis Service Businessreportable segmentsegment assetsat 2023-09-30¥545m
Remote Image Diagnosis Service Businessreportable segmentsegment profit2022-10-01 → 2023-09-30¥56m
Total Medical Solution Businessreportable segmentcapex2022-10-01 → 2023-09-30¥30m
Total Medical Solution Businessreportable segmentdepreciation2022-10-01 → 2023-09-30¥81m
Total Medical Solution Businessreportable segmentrevenue2022-10-01 → 2023-09-30¥25.5bn
Total Medical Solution Businessreportable segmentrevenue external2022-10-01 → 2023-09-30¥25.5bn
Total Medical Solution Businessreportable segmentsegment assetsat 2023-09-30¥14.1bn
Total Medical Solution Businessreportable segmentsegment profit2022-10-01 → 2023-09-30¥371m
Total Of Reportable Segments And Otherssegment totalcapex2022-10-01 → 2023-09-30¥81m
Total Of Reportable Segments And Otherssegment totaldepreciation2022-10-01 → 2023-09-30¥104m
Total Of Reportable Segments And Otherssegment totalrevenue2022-10-01 → 2023-09-30¥26.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-10-01 → 2023-09-30¥26.6bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2023-09-30¥14.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-10-01 → 2023-09-30¥438m
Total Medical Solution Businessreportable segmentemployeesat 2024-09-30134 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,398
ItemContextValueUnit
Average number of temporary workersPrior2YearInstant_NonConsolidatedMember10
Average number of temporary workersPrior1YearInstant_NonConsolidatedMember10
Average number of temporary workersCurrentYearInstant_NonConsolidatedMember9
Total shareholder returnPrior4YearInstant_NonConsolidatedMember-
Total shareholder returnPrior3YearInstant_NonConsolidatedMember1.368
Total shareholder returnPrior2YearInstant_NonConsolidatedMember1.002
Total shareholder returnPrior1YearInstant_NonConsolidatedMember1.216
Total shareholder returnCurrentYearInstant_NonConsolidatedMember1.376
Total return on share price indexPrior4YearInstant_NonConsolidatedMember-
Total return on share price indexPrior3YearInstant_NonConsolidatedMember1.275
Total return on share price indexPrior2YearInstant_NonConsolidatedMember1.184
Total return on share price indexPrior1YearInstant_NonConsolidatedMember1.537
Total return on share price indexCurrentYearInstant_NonConsolidatedMember1.792
Number of employeesCurrentYearInstant_jpcrp030000-asr_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember148
Average number of temporary workersCurrentYearInstant_jpcrp030000-asr_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember14
Number of employeesCurrentYearInstant_jpcrp030000-asr_E34455-000RemoteImageDiagnosisServiceBusinessReportableSegmentMember13
Average number of temporary workersCurrentYearInstant_jpcrp030000-asr_E34455-000RemoteImageDiagnosisServiceBusinessReportableSegmentMember-
Number of employeesCurrentYearInstant_jpcrp030000-asr_E34455-000FoodServiceReportableSegmentMember9
Average number of temporary workersCurrentYearInstant_jpcrp030000-asr_E34455-000FoodServiceReportableSegmentMember48
Number of employeesCurrentYearInstant170
Average number of temporary workersCurrentYearInstant62
Number of employeesCurrentYearInstant_NonConsolidatedMember134
Average age years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember38.7
Average length of service years information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember8.2
Average annual salary information about reporting company information about employeesCurrentYearInstant_NonConsolidatedMember7114000JPY
Average number of temporary workersCurrentYearInstant_NonConsolidatedMember9
Number of employeesCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember134
Average number of temporary workersCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember9
Number of employeesCurrentYearInstant_NonConsolidatedMember134
Average number of temporary workersCurrentYearInstant_NonConsolidatedMember9
Ratio of female employees in managerial positions metrics of reporting companyCurrentYearInstant_NonConsolidatedMember0.137
Capital expenditures overview of capital expenditures etcCurrentYearDuration44057000JPY
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember1967800
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember5903400
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant1967800
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant5903400
Number of shares constituting one unitCurrentYearInstant_OrdinaryShareMember100
Number of shareholders national and local governmentsCurrentYearInstant_OrdinaryShareMember-
Number of shareholders financial institutionsCurrentYearInstant_OrdinaryShareMember1
Number of shareholders financial service providersCurrentYearInstant_OrdinaryShareMember10
Number of shareholders other corporationsCurrentYearInstant_OrdinaryShareMember17
Number of shareholders foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember10
Number of shareholders foreign individual investorsCurrentYearInstant_OrdinaryShareMember-
Number of shareholders individuals and othersCurrentYearInstant_OrdinaryShareMember394
Number of shareholders totalCurrentYearInstant_OrdinaryShareMember432
Number of shares held number of units national and local governmentsCurrentYearInstant_OrdinaryShareMember-
Number of shares held number of units financial institutionsCurrentYearInstant_OrdinaryShareMember1
Number of shares held number of units financial service providersCurrentYearInstant_OrdinaryShareMember605
Number of shares held number of units other corporationsCurrentYearInstant_OrdinaryShareMember12119
Number of shares held number of units foreign investors other than individualsCurrentYearInstant_OrdinaryShareMember330

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2023-09-30pass
balance sheet identityconsolidated 2024-09-30pass
balance sheet identitynon_consolidated 2023-09-30pass rounding
balance sheet identitynon_consolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · net assetsnon_consolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2022-10-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2023-10-01/2024-09-30pass
statement vs summary · revenueconsolidated 2022-10-01/2023-09-30pass
statement vs summary · revenueconsolidated 2023-10-01/2024-09-30pass
statement vs summary · revenuenon_consolidated 2022-10-01/2023-09-30pass
statement vs summary · revenuenon_consolidated 2023-10-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2023-09-30pass
statement vs summary · total assetsconsolidated 2024-09-30pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass
statement vs summary · total assetsnon_consolidated 2024-09-30pass